In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Influenza Tests are laboratory based tests used to identify active or suspected influenza infections, using a combination of molecular diagnostics and immunoassay. GlobalData uses proprietary data and analytics to provide a comprehensive report on the influenza tests devices market, including market shares of different players within Belgium. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the influenza tests market in Belgium was Abbott Laboratories followed by Quidelortho, Danaher, F. Hoffmann-La Roche, DiaSorin, Becton Dickinson and Co, Sekisui Diagnostics and Thermo Fisher Scientific.
This segment includes Influenza Antigen Tests, Influenza Multiplex NAATs, and Influenza Lowplex Nucleic Acid Amplification Tests (NAATs)
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the influenza tests devices market within Belgium was expected to be over $0.02m in 2022.
For the latest complete market share analysis of influenza tests device market in Belgium, buy the report here.